Vifor Pharma Group, formerly Galenica Group, is a global pharmaceutical company that researches, develops, produces and markets its own pharmaceutical products and is the partner of choice for innovative, patient-focused solutions. The company’s goal is to be a global leader in iron deficiency, nephrology and cardio-renal therapies and strives to help patients around the world with severe and chronic diseases to lead better, healthier lives. Vifor Pharma Group has production sites in Switzerland and Portugal as well as a dynamic network of affiliates and partners offering broad market coverage all over the world.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Vifor Pharma AG - Registered Shares?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Vifor Pharma AG - Registered Shares market cap is $11.76B.
What is the 52-week high for Vifor Pharma AG - Registered Shares?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Vifor Pharma AG - Registered Shares 52 week high is $183.50 as of September 06, 2025.
What is the 52-week low for Vifor Pharma AG - Registered Shares?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Vifor Pharma AG - Registered Shares 52 week low is $112.75 as of September 06, 2025.
What is Vifor Pharma AG - Registered Shares stock price today?
Vifor Pharma AG - Registered Shares stock price today is $181.25.
What was Vifor Pharma AG - Registered Shares stock price yesterday?
Vifor Pharma AG - Registered Shares stock price yesterday was $174.25.
What is the PE ratio of Vifor Pharma AG - Registered Shares?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Vifor Pharma AG - Registered Shares’s P/E ratio is 74.07.
What is the Price-to-Book ratio of Vifor Pharma AG - Registered Shares?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Vifor Pharma AG - Registered Shares P/B ratio is 3.0707.
What is the 50-day moving average of Vifor Pharma AG - Registered Shares?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Vifor Pharma AG - Registered Shares 50-day moving average is $180.41.
